These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 2911314
1. Antibodies to Strongyloides stercoralis in healthy Jamaican carriers of HTLV-1. Nera FA, Murphy EL, Gam A, Hanchard B, Figueroa JP, Blattner WA. N Engl J Med; 1989 Jan 26; 320(4):252-3. PubMed ID: 2911314 [No Abstract] [Full Text] [Related]
2. Is the prevalence of HTLV-1 infection higher in Strongyloides carriers than in non-carriers? Arakaki T, Asato R, Ikeshiro T, Sakiyama K, Iwanaga M. Trop Med Parasitol; 1992 Sep 26; 43(3):199-200. PubMed ID: 1470843 [Abstract] [Full Text] [Related]
3. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis. Carvalho EM, Da Fonseca Porto A. Parasite Immunol; 2004 Sep 26; 26(11-12):487-97. PubMed ID: 15771684 [Abstract] [Full Text] [Related]
4. Epidemiologic study of the association between human T-cell lymphotropic virus type 1 and Strongyloides stercoralis infection in female blood donors (Guadeloupe, French West Indies). Courouble G, Rouet F, Herrmann-Storck C, Nicolas M, Candolfi E, Deloumeaux J, Carme B. West Indian Med J; 2004 Jan 26; 53(1):3-6. PubMed ID: 15114885 [Abstract] [Full Text] [Related]
6. [Enterococcal meningitis due to strongyloidiasis with HTLV-1 carrier]. Sugiura A, Fujimoto M, Saida Y. Rinsho Shinkeigaku; 2006 Oct 26; 46(10):715-7. PubMed ID: 17323782 [Abstract] [Full Text] [Related]
7. Severe strongyloidiasis complicated by meningitis and hydrocephalus in an HTLV-1 carrier with increased proviral load. Satoh M, Futami A, Takahira K, Kodaira M, Tanaka T, Kuriki K, Hori E. J Infect Chemother; 2003 Dec 26; 9(4):355-7. PubMed ID: 14691660 [Abstract] [Full Text] [Related]
8. Correlation between human T cell lymphotropic virus type-1 and Strongyloides stercoralis infections and serum immunoglobulin E responses in residents of Okinawa, Japan. Hayashi J, Kishihara Y, Yoshimura E, Furusyo N, Yamaji K, Kawakami Y, Murakami H, Kashiwagi S. Am J Trop Med Hyg; 1997 Jan 26; 56(1):71-5. PubMed ID: 9063365 [Abstract] [Full Text] [Related]
9. Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1. Satoh M, Toma H, Sato Y, Takara M, Shiroma Y, Kiyuna S, Hirayama K. Clin Exp Immunol; 2002 Feb 26; 127(2):354-9. PubMed ID: 11876761 [Abstract] [Full Text] [Related]
14. Seroprevalence of Strongyloides stercoralis infection among HTLV-I infected blood donors in Barcelona, Spain: A cross-sectional study. Salvador F, Sulleiro E, Piron M, Sánchez-Montalvá A, Sauleda S, Molina I. Acta Trop; 2017 Dec 26; 176():412-414. PubMed ID: 28939495 [Abstract] [Full Text] [Related]